Table 1 Overview of study features and admission characteristics of 1,094 participants

Age

18 – 29 years

298 (27.2%)

53 (25.1%)

245 (27.7%)

30 – 39 years

282 (25.8%)

56 (26.5%)

226 (25.6%)

40 – 49 years

193 (17.6%)

40 (19.0%)

153 (17.3%)

50 – 59 years

114 (10.4%)

23 (10.9%)

91 (10.3%)

60 – 69 years

110 (10.1%)

25 (11.8%)

85 (9.6%)

≥ 70 years

97 (8.9%)

14 (6.6%)

83 (9.4%)

Sex

Female

535 (48.9%)

99 (46.9%)

436 (49.4)

Male

559 (51.1)

112 (53.1%)

447 (50.6%)

TB History

No prior TB

1,018 (93.1%)

176 (83.4%)

842 (95.4%)

First line only

48(4.3%)

23 (10.9%)

25 (2.8%)

Second line

28 (2.6%)

12 (5.7%)

16 (1.8%)

HIV

Negative

404 (36.9%)

9 (4.3%)

395 (44.7%)

Positive

690 (63.1%)

202 (5.7%)

488 (55.3%)

CD4 count

< 50 cells/mL

58 (8.4%)

20 (9.9%)

38 (7.8%)

50 – 99 cells/mL

100 (14.5%)

28 (13.9%)

72 (14.8%)

100 – 249 cells/mL

170 (24.6%)

51 (25.2%)

119 (24.4%)

250 – 349 cells/mL

203 (29.4%)

53 (26.2%)

150 (30.7%)

350 – 499 cells/mL

73 (10.6%)

22 (10.9%)

51 (10.5%)

≥ 500

86 (12.5%)

28 (13.9%)

58 (11.9%)

ART before admission

217 (31.4%)

54 (26.7%)

163 (33.4%)

ART during admission

255 (37%)

78 (38.6%)

177(6.2%)